These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 1930379)

  • 61. Role of the employee assistance program in helping the troubled worker.
    Fitzgerald ST; Hammond SC; Harder KA
    Occup Med; 1989; 4(2):233-43. PubMed ID: 2658148
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Preventing upper extremity cumulative trauma disorders. An approach to employee wellness.
    Fisher TF
    AAOHN J; 1998 Jun; 46(6):296-301. PubMed ID: 9748907
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The economic impact of alcohol abuse and alcoholism.
    Burke TR
    Public Health Rep; 1988; 103(6):564-8. PubMed ID: 3141948
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Occupational health services for municipal employees.
    Higgins P; Ezike C; Orris P
    Occup Med; 2001; 16(1):11-21. PubMed ID: 11107221
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Drug screening in the workplace: use, abuse and implications.
    Grabowski J; Silverman PB
    NIDA Res Monogr; 1989; 95():225-31. PubMed ID: 2640968
    [No Abstract]   [Full Text] [Related]  

  • 66. Drug & alcohol testing. Oral fluid testing update.
    Andrie M
    Occup Health Saf; 2001 Aug; 70(8):32-4. PubMed ID: 11523283
    [No Abstract]   [Full Text] [Related]  

  • 67. Random drug testing: a commitment to a drug free workplace.
    Smith NG
    AAOHN J; 1993 Apr; 41(4):193-4. PubMed ID: 8507286
    [No Abstract]   [Full Text] [Related]  

  • 68. The role of the occupational physician in substance abuse.
    Lambert SD
    Occup Med; 2002; 17(1):1-12, iii. PubMed ID: 11726332
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Drug screening & the ADA.
    Watts C
    Occup Health Saf; 2001 Apr; 70(4):80-2. PubMed ID: 11326588
    [No Abstract]   [Full Text] [Related]  

  • 70. Testing for drugs of abuse in urine.
    Turk J
    Mo Med; 1989 Jun; 86(6):337-40. PubMed ID: 2755453
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Substance abusers. Terminate or treat?
    Gemignani J
    Bus Health; 1999 Jun; 17(6):32-4, 37-9. PubMed ID: 10538201
    [No Abstract]   [Full Text] [Related]  

  • 72. Types of drug-testing programmes in the workplace.
    Mørland J
    Bull Narc; 1993; 45(2):83-113. PubMed ID: 7920543
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fostering a drug-free workplace.
    Montoya ID; Elwood WN
    Health Care Superv; 1995 Sep; 14(1):1-13. PubMed ID: 10172396
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Drug and alcohol testing in the workplace--objectives, pitfalls, and guidelines.
    Schottenfeld RS
    Am J Drug Alcohol Abuse; 1989; 15(4):413-27. PubMed ID: 2688397
    [TBL] [Abstract][Full Text] [Related]  

  • 75. An analysis of drug abuse policies in teaching hospitals.
    Montoya ID; Carlson JW; Richard AJ
    J Behav Health Serv Res; 1999 Feb; 26(1):28-38. PubMed ID: 10069139
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Legislation concerning alcohol and drug intake in the workplace].
    Goszczyńiska E
    Med Pr; 2013; 64(4):593-608. PubMed ID: 24502123
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A comprehensive reproductive health program in the workplace.
    Brooks L; Merkel SF; Glowatz M; Comstock ML; Shoner LG
    Am Ind Hyg Assoc J; 1994 Apr; 55(4):352-7. PubMed ID: 8209841
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Drug abuse tests important part of preventive measures against narcotics. With testing drug abuse can be identified early in the workplace].
    Hermansson U; Beck O; Westregård A; Brunes M
    Lakartidningen; 2010 Nov 17-23; 107(46):2878-80. PubMed ID: 21197782
    [No Abstract]   [Full Text] [Related]  

  • 79. Substance abuse. Taking the lead in workplace policies.
    Kogan H
    Occup Health (Lond); 1992 Nov; 44(11):342-4. PubMed ID: 1301526
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A protocol to evaluate drug-related workplace impairment.
    Reisfield GM; Shults T; Demery J; Dupont R
    J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):43-8. PubMed ID: 23527668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.